WHO Drug Information Vol. 19, No. 3, 2005
(2005; 72 pages) Ver el documento en el formato PDF
Índice de contenido
Abrir esta carpeta y ver su contenidoPersonal Perspectives
Abrir esta carpeta y ver su contenidoSafety and Efficacy Issues
Abrir esta carpeta y ver su contenidoHerbal Medicines
Abrir esta carpeta y ver su contenidoRegulatory Action and News
Cerrar esta carpetaEssential Medicines
Cerrar esta carpetaHighlights of the 14th Model List of Essential Medicines
Ver el documentoMethadone and buprenorphine
Ver el documentoMifepristone with misoprostol
Ver el documentoWHO Model List of Essential Medicines
Abrir esta carpeta y ver su contenidoAccess to Medicines
Abrir esta carpeta y ver su contenidoThe International Pharmacopoeia
Ver el documentoRecommended International Nonproprietary Names: List 54
 

Highlights of the 14th Model List of Essential Medicines

The WHO Expert Committee on the Selection and Use of Essential Medicines met in Geneva in March 2005. Their task was to evaluate evidence-based material relating to the maintenance and updating of the Model List of Essential Medicines. The Model List presents a list of minimum medicine needs for a basic health care system, listing the most efficacious, safe and cost effective medicines for priority conditions. Two important items from the draft report (http://www.who.int/medicines/library/general/1-ReportFinal-unedited_010705.pdf) are presented below and the latest revision of the 14th Model List of Essential Medicines can be found on page 224.

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 24 abril 2012